Alterations in Cardiovascular Parameters in 5xFAD Murine Model
- PMID: 41215534
- PMCID: PMC12603476
- DOI: 10.1002/cbf.70138
Alterations in Cardiovascular Parameters in 5xFAD Murine Model
Abstract
Alzheimer's Disease (AD) is a global health issue, affecting over 6 million people in the United States, with that number expected to increase as the population ages. As a neurodegenerative disorder that affects memory and cognitive functions, it is well established that AD is associated with cardiovascular risk factors beyond only cerebral decline. In this study, we measured hemodynamic parameters related to cardiovascular and cerebrovascular function in 5xFAD mice with AD and their littermates. Specifically, we measured cardiovascular pulse wave velocity parameters, a marker of arterial stiffness and cardiovascular risk, and cerebrovascular pulse wave velocity, a novel technique to measure cerebral arterial stiffness. Our results showed that while 5xFAD mice exhibited significant differences in ejection time, pulse pressure, and Tei index, many other cardiovascular and cerebral parameters were not different. Despite reports that amyloid plaque deposition begins at an early age of 1.5 months in 5xFAD mice, our results did not indicate significant cardiovascular changes. Studies to elucidate cardiovascular and cerebrovascular parametric changes should be done at later ages where the underlying changes are more profound.
Keywords: 5xFAD; alzheimer's disease; cardiovascular disease; pulse wave velocity.
© 2025 The Author(s). Cell Biochemistry and Function published by John Wiley & Sons Ltd.
Figures
Update of
-
Methods to Utilize Pulse Wave Velocity to Measure Alterations in Cerebral and Cardiovascular Parameters.bioRxiv [Preprint]. 2024 May 15:2023.06.22.546154. doi: 10.1101/2023.06.22.546154. bioRxiv. 2024. Update in: Cell Biochem Funct. 2025 Nov;43(11):e70138. doi: 10.1002/cbf.70138. PMID: 38798364 Free PMC article. Updated. Preprint.
References
MeSH terms
Grants and funding
- R21 TW012635/TW/FIC NIH HHS/United States
- This study is supported by National Institute of Health (NIH) NIDDK T-32, number DK007563 entitled Multidisciplinary Training in Molecular Endocrinology to Z.V.; The Fogarty International Center and National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health grants 2D43TW009744 and R21TW012635. The American Heart Association Award Number 24IVPHA1297559 (https://doi.org/10.58275/AHA.24IVPHA1297559.pc.gr.193866). The United Negro College Fund/Bristol-Myers Squibb E.E. Just Faculty Fund, Burroughs Wellcome Fund Career Awards at the Scientific Interface Award, Burroughs Wellcome Fund Ad-hoc Award, National Institutes of Health Small Research Pilot Subaward to 5R25HL106365-12 from the National Institutes of Health PRIDE Program, DK020593, Vanderbilt Diabetes and Research Training Center for DRTC Alzheimer's Disease Pilot & Feasibility Program to A.H.J. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- R25 HL106365/HL/NHLBI NIH HHS/United States
- P30 DK020593/DK/NIDDK NIH HHS/United States
- D43 TW009744/TW/FIC NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
